Mas Ahmed is an consultant paediatrician with interest in paediatric neurology/ Paediatric unit medical student lead (Queen’s University Hospital / King George’s Hospital). I am a honrary senior lecture at the University College London. I deliver service for children with paediatric problems (acute and chronic), epilepsy, headaches and neurological problems. I am active in clinical research and audit.

Paediatric Neurology, Epilepsy, Headaches

J P N Mishra has his basic expertise in Life Science with specialization in human physiology. His previous dimensions of research included the discipline of neurobiology, sleep medicine and yogic yciences. He has explored the mechanism of operation in circadian rhythm and sleep quality following yoga practices. His area of research also includes applied efficacy of different natural phytochemicals on various carcinoma cells

Human physiology, Neurology, sleep medicine

Prof. Emeritus Stavros J Baloyannis was born in Thessaloniki, Greece. He graduated from the School of Medicine of Aristotelian University of Thessaloniki, Postgraduate training (a) in Neurology in Aristotelian University and Institute of Neurology, Queen Square, London, (b) in Neuropathology in Institute of Neurology, Queen Square, Catholic University of Louvain, University of Pennsylvania, Philadelphia, USA (c) in Neurootology and Neuropathology of Auditory pathway in Harvard University, (d). Neuropathology and Experimental Neurology, University of Pennsylvania, (e) Neuroimmunology, Yale University. Member of 40 scientific societies in Greece and abroad. Honorary Member of the Academy of Hellenic Air Forces. President of the Society for the amelioration of the quality of life in chronic neurological diseases. President of the Orthodox Medical Association for support of health and medical education in Africa. He was a visiting professor at Tufts University, Democratic University, Aristotelian University, School of Theology, Aristotelian University, School of Philosophy. Author of 28 textbooks on Neurology, Neuropathology, Neuropsychology and of 678 papers, published in Greek and International Journals on Neurology, Neuropathology, Neuroimmunology and Neurotics. Head of the 1st Department of Neurology, Aristotelian University for 20 years (1992-2011).Emeritus Professor of Neurology, Aristotelian University, Thessaloniki, Greece. Director of Research Institute for Alzheimer’s disease, Iraklion, Langada.

Neurosciences, medical ethics, neurophilosopy, brain and the arts, neurolinguistics, music and the brain, history of neurology and medical education. HIs research was focused on electron microscopy and neuropathology of Alzheimer's disease , ageing and degenerative conditions of the central nervous system

Walter Bini has completed his Diploma from Westminster School, Simsbury Connecticut, USA and his Post-graduate Degree from Universidad de Zaragoza, Facultad de Medicina, Zaragoza, Spain. He is a long time direct co-worker of Prof. Dr. Madjid Samii in Hannover, Germany. Presently since 2014, he is Middle East Chairman of ISLASS. He was the Head of Neurosurgery at Sheikh Khalifa General Hospital, UAQ–UAE from 2014–2016. Currently, he is the Lead Neurosurgeon responsible for spinal surgery in the Waldkrankenhaus for special surgeries by Leipzig in Germany -Trauma, Sport and Spine Department and also a Visiting Consultant Neurosurgeon of the Orthopaedic Department at Healthpoint Hospital in Abu Dhabi, UAE. He is an Executive Board Member and Dean of the Faculty of the WAMS and also holds a Faculty position at the London Medical Education Academy, UK.

Micro neurosurgery, special interest and expertise in the management of head trauma, Neuro-oncology, stereotaxy and radiosurgery, spinal surgery including less invasive techniques and Neuroradiology

Mojtaba Mafi is a physician/Medical Doctor. He received M.D. degree from Tehran university school of Medicine with honors and passed successfully many post graduate Medical education programs approved by Medical Sciences University. He worked clinically in Neurosurgery ward Shariati hospital for Thesis on Brain tumors and Meningioma for 6 years till 2008. He is now active in clinical setting and scientific field. Dr Mojtaba Mafi is invited speaker in Global and European neurosurgery and neurology conferences in Rome, Italy and London. He is invited editorial board member of psychology and neuroscience journal. He is speaker of world congress on neuronal synchronization, London 2018 and speaker of International Neuro oncology conference in Dubai, September 2018. He is honourable speaker of 26th International Neurology conference in Japan. Dr Mojtaba Mafi is Board member of International journal of psychology and neuroscience. Dr Mafi is Speaker of 5th annual conference on stroke and Neurodisorders, Turkey, November 2018.

Neurology, Neuroscience, Neuro-oncology, Neurosurgery specialised in Brain tumors and meningioma

Pousette Farouk Gaber Hamed is an Egyptian physician and a ‘Member of the Egyptian society of Neurology, Psychiatry, and Neurosurgery’ started career as a House Officer (1999-2000) at Ain Shams university Hospitals and then as a Resident in Neurology in Neurocritical care department of Ain Shams university Hospitals (2000-2004), worked as an Assistant lecturer in Neurology for 3 years and promoted as Lecturer in Neurology at Ain Shams university hospitals from 2008 till now and also served as a Neurologist in Ibn Sina Tertiary neurology hospital in Kuwait. She is specialized in management of cerebrovascular stroke patients, epilepsy, movement disorders, and general neurology cases and Professional Diploma in the research statistics SPSS from American university in Cairo.

Management of cerebrovascular stroke patients, epilepsy, movement disorders, and general neurology cases

He was graduated as Doctor of Medicine in Kasr Aini Institute, Cairo, Egypt 1981, Since then he practiced in different countries and got different certificates in Pediatrics and pediatric Neurology. Those included Syria, Ireland, England, Canada and mostly Saudi Arabia. Dr. Mahmoud having worked in Sick Kids, Toronto as a fellow of pediatric Neurology, got the chance to work in the field of ketogenic diet. As well he is interested in neurodysmorphology and movement disorders. He is a mentor of many candidates who got the British Pediatric Neurology courses in the last few years. He has more than 40 studies and papers in the field of child Neurology and he mentors a lot of residents and fellows in the pediatric Neurology programs running in the center that is related to KFMC National Neuroscience Institute.

Pediatrics, Pediatric Neurology; Neonatology

Dr. Angel Molina Leon is a clinical Neurophysiologist. He obtained his Degree in Neurophysiology from Hospital Complex of Toledo. He has undergone training in various fields like Neurology, Internal Medicine, Neuropaediatric ward, psychiatric ward, Electroencephalography, Electromyography and Sensorimotor Conduction, and undergone training for 3 years at General Sleep Disorders Unit at Hospital Complex of Toledo and Epilepsy & Electrocorticography at King’s college Hospital, London. He has a 8 years professional experience in the Neurophysiology Clinic in the Private Medical Centre Virgen de la Caridad, in Cartagena, Murcia, Spain which works in conjunction with the Social Security hospitals and he has professional experience in confirming and diagnosing a wide and varied range of neuromuscular pathologies by means of electromyography and electrocephalogram /polysomnography, and multimodal evoked potential responses. He was in charge of evaluating patients with various sleep disorders particularly; apnoea, narcolepsy, restless legs syndrome, REM nightmares, night-terrors, sleep paralysis, nocturnal epilepsy, hypersomnia with the evaluation of more than 500 patients a year and 150 night polysomnographies a year.

Neurology, Research Techniques in Neurology, Neurobiology of sleep, Physiology of excitable membranes, Inter-functional relation between the nervous and immune system.

Prof. Harry Steinbusch is appointed as Professor in Cellular Neuroscience at the Department of Psychiatry and Neuropsychology, Past-Director of the School for Mental Health and Neuroscience, Founding- Director of the European Graduate School for Neuroscience at Maastricht University and currently President-Elect of the Neurotoxicity Society. Recently he is appointed as Fellow of the Indian Society for Neurosciences, as Adjunctive Professor at Kyoto Prefectural University of Medicine in Japan, as Adjunctive Professor at University of Colombo, Sri Lanka. He is the founding editor of the Journal of Chemical Neuroanatomy, IF: 2.2. His research is focused on neurodevelopmental influences towards depression and neurodegenerative diseases studied in animal models. This implies combining a broad range of techniques, i.e. molecular neurobiology, quantitative neuromorphology, animal behavior and epigenetics. He has thus far guided 96 Ph.D. students. He has been involved as the director of the travel IBRO program. He has been twice coordinator of a Marie Curie Early Stage Training site. His current Hirsch factor is 83; publications: 475; citations without self-citations: 29,613.

Neuroanatomy, Neurodegeneration, Alzheimer, Depression.

-

-

-

-

-

-

Dr. George Perry is currently the dean of the College of Sciences and professor of biology at the University of Texas at San Antonio. After graduation in Zoology from University of California, Santa Barbara, he headed to Scripps Institution of Oceanography and also studied at Hopkins Marine Station of Stanford University and the Marine Biological Laboratory of Woods Hole and obtained his PhD in Marine Biology in 1979. Dr. Perry joined the faculty of Case Western Reserve University in 1995, where he currently holds an adjunct appointment. He is a Fellow of the American Association for the Advancement of Sciences, Microscopy Society of America, Royal Society of Medicine, Royal Society of Chemistry, Society of Biology and the Linnean Society and past-president of the American Association of Neuropathologists. He has been elected member of the Spanish Royal Academy of Sciences, Mexican Academy of Sciences and Academy of Sciences Lisbon; Iberoamerican Molecular Biology Organization, Dana Alliance for Brain Initiatives and won the Distinguished Professional Mentor Award from the Society for the Advancement of Chicanos and Native Americans in Science, Senior Investigator Award from the International College of Geriatric psychoneuropharmacology, Senior Fulbright Fellow and the National Honor Plaque of Panama for exceptional contributions to Neuroscience. Dr. Perry is on Board of the National Organization of Portuguese Americans and serves as Director of Education and Research.

-

-

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. Professor Tang completed his medical training at the Chinese University of Hong Kong. He joined the Chinese University of Hong Kong as an academic staff since 1999. His main research area is Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

-

-

Vahe Poghosyan received his MSc in Mathematics (1997) from Yerevan State University and PhD in Neurophysiology (2000) from National Academy of Sciences of Armenia. He held positions of Research Scientist in RIKEN Brain Science Institute in Japan (2000-2007), and Senior Scientist (2007-2016) and Director of Research Training Program (2011-2016) at AAI Scientific Cultural Services Ltd. in Cyprus. Currently, he is the Head of MEG Laboratory and Consultant Neuronavigation at King Fahad Medical City in Riyadh, KSA.

Dr. Gjumrakch Aliev, MD, PhD, President “GALLY” International Biomedical Research Institute Inc., San Antonio, Texas, USA. Professor of Cardiovascular, Neuropathology, Gerontology, Health Science and Healthcare Administration at University of Atlanta, Atlanta, Georgia, USA. Leading Scientist, Institute of Physiologically Active Compounds. Russian Academy of Sciences

neurodegenerative diseases research (Alzheimer disease)

He's heading the medical image processing department and BioFlowImage research te

CSF research and applies the non-invasive hydrodynamic approach in clinical practice

Finsterer J. received his M.D. and Prof. of Neurology from the University of Vienna, Austria. Since his training as a clinical neurologist and electrophysiologist at the Neurological Krankenhaus Rosenhuegel and the Ludwig Boltzmann Institute for Epilepsy and Neuromuscular Disorders he is involved in the management of neuromuscular disorders, particularly muscular dystrophies and metabolic myopathies. In addition to neuromuscular disorders, research interests focus on genetics, orphan diseases, and cardiac involvement in genetic conditions.

Neuromuscular disorders

Ling Li, Ph.D. and MD, Neurologist, Chief Physician，Professor, Supervisor for Doctor, Director of Pediatric Neurology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine. Shanghai, China. Her research includes "The Expressions and Neuroprotection of Brain-Derived Neurotrophic Factor (BDNF) in bacterial meningitis".

Neuroprotection of Brain-Derived Neurotrophic Factor (BDNF) in bacterial meningitis

Sergei Funikov has acquired his PhD at the Engelhardt Institute of Molecular Biology of Russian Academy of Sciences. His main research focuses on the studying the regulation of small non-coding RNAs (in particular, microRNAs and Piwi-interacting RNAs) in stress response as well as investigation the immune and neuroprotective properties of human recombinant heat shock protein 70 (Hsp70). His last study concerns the molecular aspects underlying the progression of motor neurons failure on the model recapitulating the clinical symptoms of amyotrophic lateral sclerosis

regulation of small non-coding RNAs

Dr. Svetlov has expertise and international recognition for studies of traumatic brain injury (TBI), especially combat-related blast TBI proven by a number of publications and awards from Department of Defense on molecular signatures and biomarkers of blast brain injury and US patents. The goal is to determine and characterize biomarkers reflecting chronic encephalopathy, including neuroinflammation and impaired neurogenesis and repair. Dr. Svetlov is a chief scientific officer at Immunova, LLC, a biopharmaceutical company fully licensed Dr. Svetlov technology and adjunct research associate professor at UF Medicine/Psychiatry

neuroinflammation and impaired neurogenesis and repair

Fakher rahim has his expertise in evaluation and passion in improving the health and wellbeing. His open and contextual evaluation model based on association and risk assessment of various disease creates new data especially in the field of molecular epidemiology for improving healthcare. He used several models after years of experience in research both in hospital and research institutions

neuronal mechanisms, parasympathetic hyperactivity or mast cell degranulation

Dr Tankesh Kumar have been trying to find out the role of sleep in consolidation of fear conditioned memory from the past 10 years. He always raise the questions (i) if sleep is important for fearful memory consolidation then what time of the day will have more or less impact and its pivotal causative mechanism (ii) Different sleep stage has distinct role in memory consolidation and formation. So, which sleep stage (NREM/ REM and both) or sleep homeostasis might be playing permissible role for fear memory consolidation. It is being discussed globally from several years that how to erase bad/negative memories in human. Our results that post-learning NREM sleep facilitates CuFC memory consolidation suggest that short-term sleep deprivation soon after experiencing traumatic events could potentially be used to prevent the consolidation of negative memories. However, it needs further study, mainly on human subjects before the approach is adapted for therapeutic use

sleep in consolidation of fear conditioned memory

Prof. Muhammad Mahajnah is an Assistance professor of pediatrics and pediatrics neurology at the Technion faculty of Medicine, Israel. He received his medical degree from Bruce and Ruth Rappaport Faculty of Medicine, Technion, 31096 Haifa, Israel in 1992 and his PhD degree in 1998. He trained in Pediatrics at Carmel Medical Center and completed fellowship in Pediatric Neurology at Schneider Children Medical Center, Tel Aviv. He has worked with children neurological disorder for about 20 years and has a special interest in neurodevelopmental disorders and neurogenetic disorders and devotes his time to both clinical work and research

neurogenetic disorders

Founding Member (2007) and Prime Vice-President of the Romanian Society for Neurorehabilitation (RoSNeRa) - affiliated to WFNR. Founding Member and Prime Vice-President of the Romanian Spinal Cord Society (RoSCoS) - affiliated to ISCoS) and ESCIF. Member of the International Spinal Cord Society (ISCoS, since 2000), World Federation for Neurorehabiliation (WFNR, since 2008), Euroacademia Multidisciplinaria Neurotraumatologica (EMN, since European Federation of NeuroRehabilitation (since 2014), International Parkinson and Movement Disorder Society (since 2016), and in many Romanian Scientific Societies. Coordinator of the Romanian team in 5 international projects, participant in 4 national projects. He participated to the educational project "eleanSCI.org", launched by ISCoS in 2012.

Actively implied in national educational prophylactic interventions, aimed to prevent severe central nervous lesions (TBI and SCI ─ http://www.worldsciday.org/romania_avs.html “Prevention of SCI AV for General Public 00:15 secs”). Co-author of 2 patent certificates (appointed by the Romanian State Office for Inventions and Marks, OSIM), 9 books, and over 60 published papers. Fluently in English and French.

Yingxu Wang is professor of cognitive informatics, brain science and denotational mathematics. He is President of International Institute of Cognitive Informatics and Cognitive Computing (ICIC). He is Fellows of BCS, ICIC, WIF, and Senior Members of IEEE and ACM. He has held visiting professor positions at Oxford University (’95), Stanford University (‘08|’16), UC Berkeley (‘08), and MIT (‘12). He is the initiator of fields of cognitive informatics, denotational mathematics, abstract intelligence (aI), neural circuit theory, formal brain models, cognitive robots and cognitive machine learning. He is a top 2.5% scholar worldwide and top 10 at UCalgary according to Research Gate’s statistics

Neuroinformatics, neurology, neural signaling systems, spike frequency modulation, SFM, cognitive informatics, mathematical models, neural networks, cognitive system, cognitive robots, brain-machine interface

Biography DR. MANUEL VELASCO STUDIES: HIGH SCHOOL AND COLLEGE: Liceo Francisco de Miranda, Los Teques, Venezuela, 1962 UNIVERSITY: Universidad Central de Venezuela, Caracas, Venezuela, 1968 POSTGRADE STUDIES: Intern IN Medicina Interna (CLINICAL PHARMACOLOGY), Hahnemann Medical College and Hospital, Philadelphia, Pa., USA. Fellowship IN Medicina Interna (CARDIOVASCULAR CLINICAL PHARMACOLOGY), Emory University School of Medicine, Atlanta, Ga., USA Julio 1972 – Diciembre 1974. DOCTORATE IN MEDICAL SCIENCES: Universidad Nacional del Zulia, Maracaibo, Estado Zulia, Venezuela, 1979. POSITIONS: Jefe de Catedra de Farmacología, Escuela de Medicina Vargas, Caracas, Venezuela, 2001-2003 Jefe de Departamento de Ciencias Fisiologicas, Escuela de Medicina Vargas, Caracas, Venezuela, 2001-2003 Coordinador General, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela, 2002-2004 Director, Unidad de Farmacología Clínica, Hospital Vargas, Caracas, Venezuela, desde 1976 Director, Unidad de Hipertensión, Hospital Vargas, Caracas, Venezuela, desde 1985. Director, Unidad de Farmacología Clinica Cardiovascular y Respiratoria, Escuela de Medicina Vargas, Caracas, Venezuela, desde 2002

RESEARCH INTERESTS: Methodology in Radioisotopes, Advance course of Biostathistics, Medical course in Radioisotopes, Advance course of clinical pharmacology.

Kenneth Blum is widely designated as Father of Psychiatric Genetics because of the of the DRD2 gene and its correlation with various psychiatric disorders including the “Reward Defi ciency Syndrome” (RDS) which term he has coined. He is also known as the “Father of Neuro- Nutrient Therapy “ for his discovery of successful nutrient therapy for RDS. He holds numerous domestic and foreign patents and is co-founder and Chairman & CSO of LifeGen Inc. He is a former Full Professor in the Department of Pharmacology, University of Texas Health Science Center, San Antonio, Texas; Volunteer Professor in the Department of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida and Adjunct Full Professor of Psychiatry at the University of Vermont College of Medicine, Burlington, Vermont. He currently serves as Neuroscience advisor for Dominion Diagnostics., LLC North Kingstown, Rhode island, Malibu Beach Recovery Center, Malibu Beach California, and is the Scientifi c Director of PATH Foundation NY, New York. He is an honorary Faculty of IIOAB, India. He has been recently appointed Chief Scientifi c Offi cer(CSO) of G&G Holistic Addiction Treatment Centers in North Miami Beach Florida. To his credit he has over 400 publications in peer reviewed journals, 14 books and has received many awards including a Lifetime Achievement Award from the National Institute of Holistic Addiction Studies.

neuropsychopharmacology,genetics,genetics of alcoholism, neuropsychiatry,pharmacogenetics and Blum's research has been recognized through numerous awards.

January 2003 – July 2005. Currently forming part of a professional training period at the General Sleep Disorders Unit in service of the Clinical Neurophysiology of the Complejo Hospitalario de Toledo, in which I was in charge of evaluating patients with various sleep disorders particularly; apnoea, narcolepsy, restless legs syndrome, REM nightmares, night-terrors, sleep paralysis, nocturnal epilepsy (55 of these patients suffer from chronic insomnia and are part of my research project), hypersomnia (2 publications) with the evaluation of more than 500 patients a year and 150 night polysomnographies a year.( Technical handling, recording and analysis). The technical handling and analysis of Multimodal evoked potentials (somatosensory, visual electroretinogram and trunk audiometry). While working at the Clinical Neurophysiology Service at the Toledo Hospital Complex I undertook a three-month July 2005- JULY de 2015, 10 YEARS professional experience in the Neurophysiology Clinic in the Private Medical Centre Virgen de la Caridad, in Cartagena, Murcia, Spain which works in conjunction with the Social Security hospitals, (Santa Maria del Rosell Hospital, Naval Hospital in Cartagena, and los Arcos Hospital in Santiago de la Ribera). During the last seven years in this Centre my work related to: 9 EEG. electroencephalography /week 45 EMG. electromyography/ week 1-2 PEAT evoked potential / week 20 PSGN polysomnography /week. Professional experience: Experience in the analysis of- electroencephalography ( young children and adults) and also: -polysomnography (System Medelec Profile y Medelec Synergy- Oxford. Keypoint Medtronic System (EMG). -Electromyography - Practical experience with analysis system PUM and sensory and motor conduction and also in electromyography. Medelec Synergy and Keypoint .-Oxford.

Neurology, Seminars of Neurology, Research Techniques in Neurology, Neurobiology of sleep, Physiology of excitable membranes, Inter-functional relation between the nervous and immune system.

Dr. Pant received his M.A. and Ph.D. degrees in Physics from Agra University, Agra, India. His postdoctoral studies were conducted on the mechanisms of electron and ion transport in model membrane systems at the Department of Biophysics at Michigan State University. He joined the Laboratory of Neurobiology in the NIMH as a senior staff fellow in 1974 with Dr. Ichiji Tasaki where he studied the function of the axonal cytoskeleton in the squid giant axon. In 1979 he moved to the NIAAA extending his studies on the neuronal cytoskeleton and the effects of alcohol on its regulation. Dr. Pant moved to the NINDS, Laboratory of Neurochemistry in 1987 where he is presently chief of the section on Cytoskeleton Regulation. His laboratory is studying the mechanisms of topographic regulation of neuronal cytoskeleton proteins by post-translational modification, including the role of kinase cascades in normal brain and during neurodegeneration

The major focus of this laboratory has been to study the mechanisms of topographic regulation of neuronal cytoskeletal proteins regulation by phosphorylation and neurodegeneration. In a normal physiological state, cytoskeletal proteins are phosphorylated extensively in the axonal compartment of a mature neuron. Although all the substrates, kinases, phosphatases and their regulators are synthesized in neuronal cell bodies, little or no cytoskeletal protein phosphorylation has been detected in the cell body compartment. Under a variety of neuropathological conditions, however, such as ALS, Alzheimers Disease, or Picks disease, hyperphosphorylation of these molecules has been found in abnormal aggregates within cell bodies, usually correlated with massive neuronal cell death. The mechanisms underlying these profound compartmental shifts in neuronal phosphorylation are not well understood.The normal physiological processes within neurons are controlled by signal transduction mechanisms that regulate the balance between protein kinase and protein phosphatase activities. We have shown that the most abundant and extensively phosphorylated motifs in the c-terminal domains (lys-ser-pro-, or KSP) are primarily phosphorylated by proline directed kinases, cdk5 and MAP kinases. Moreover, we have demonstrated that this phosphorylation is due to activation of the signal transduction cascade. Recently, we have focussed on the other part of this regulation, the protein phosphatases. The other project is to study the expression, regulation and role of neuronal Cdk5 in nerve cell function.Cdk5 is a unique multifunctional kinase. Unlike other cyclin-dependent kinases, it is expressed predominantly in post-mitotic neurons, its activity modulated by association with nervous system-specific propeins. Since its identification and characterization in our laboratory, we have been intensively studying its mechanisms of regulation and its role in nerve cell function.

Dr. Mohan received his Bachelor of Science (HONS) degree in Pharmacology from University of Hertfordshire, England, UK in 2002. During this time, Dr. Mohan was awarded a research scholarship to study and perform research in the USA. During his one-year research scholarship, Dr. Mohan worked on understanding genes responsible for antibiotic resistance in ocean samples collected from the South Pole.After graduating with his B.Sc., Dr. Mohan had a short stint in big pharma., with Pfizer Inc., focusing his research efforts on sexual health and urology discovery. After Pfizer, Dr. Mohan returned to the USA after being accepted onto a Ph.D. program in Biomedical Science in the Dept. of Pharmacology & Physiology, College of Medicine at Oklahoma State Univ. After publishing his work on opioid neuropharmacology and graduating with his Ph.D. in 2008 Dr. Mohan accepted a postdoctoral assistant position at the Univ. of Iowa. During his time in Iowa, Dr. Mohan concentrated on gaining valuable experience pertaining clinical pain, focusing on postoperative pain and discovery of novel targets to alleviate acute pain following surgery.Dr. Mohan served as the President for the North Central Florida Chapter of the Society for Neuroscience (SfN) from 2013 – 2014. Dr. Mohan is a member of the Society for Neuroscience, American Heart Association and the International Society for Neuroimmunology. Dr. Mohan has taught and mentored numerous undergraduate and graduate students during his research career. Dr. Mohan is currently a Advisory Board Member for the Sia Brain Awareness Foundation and a peer-reviewer for the J. of Pain Research and on the editorial board of the J. Pharmaceutical Sciences. Dr. Mohan is also a coalition member for Cabell County Substance Abuse Prevention Partnership (CCSAPP) here in Huntington, WV.

Dr. Mohan’s current research focus is on understanding the exposure of neurotoxic substances during development and how they affect neural plasticity and neurovascular of the brain.

Giuseppe Scalabrino studied at the School of Medicine of the University of Milan and received his M.D. degree magna cum laude in 1968. He has held a number of academic positions in the Faculty of Medicine of the University of Milan. He was Associate Professor of General Pathology between 1971 and 1985; full Professor of General Pathology from 1986 till 2014. He has been invited speaker in various conferences, mainly dealing with the role of polyamines in oncology and subsequently with the cobalamin (vitamin B12) neurotrophism. Among his numerous honors, he received the International Award "Roentgen" from Italian Accademia dei Lincei in Rome for oncological research in 1983. He is author of more than 100 scientific papers and reviewer of numerous International Journals. Dr. Scalabrino's studies of cobalamin neurotrophism have been mentioned and reviewed in 12 american textbooks of neurology, biochemistry, hematology, and vitaminology

From many years, Dr. Scalabrino is usually reviewer for many international journals in the field of neurobiology, oncology, and molecular biology.

Dr. Nagaraj Pushparaj is the Director & Chief Consultant at PMN Physiotherapy Speciaality Pranikha Sports Medicine Pain Relief Centre and he is currently working as a consultant Neuro Science & Sports Medicine Rehabilitation Neuro Developmental Therapist at Be Well Hospitals.

Physiotherapy, Neuro Science & Sports Medicine and Neuro Rehabilitation.

born on April 12, 1959 in Pilsum (East Friesland); 1979-1986 Medical studies at the Medical University of Hanover; 1988 Promotion (magna cum laude) with the theme "Investigations of electrophysiological, biochemical and psychometric parameters in hepatic encephalopathy "; 1990-1993 assistant physician at the psychiatric clinic, University of Göttingen; 1997 Specialist physician for psychiatry and neurology, since also lead the working group "Molecular Neurobiology" of the Psychiatric Clinic, University Goettingen. Since 1999 he has been the Clinical Director of the Psychiatric Clinic. 2001 Acquisition of the Additional description Psychotherapie / Facharzt für Psychiatrie und Psychotherapie. 2002 Habilitation, since then: Extraordinariat (C3 professorship) for psychiatry and psychotherapy; Deputy. Clinic Director & Ltd. Oberarzt, Head of the Polyclinic & Institute's Institute, FriedrichAlexander-University Erlangen-Nuremberg; Head of the Research Laboratory for Molecular Neurobiology, clinic with polyclinic for psychiatry and psychotherapy, Friedrich-AlexanderUniversität Erlangen-Nuremberg

Molecular Neurobiology,psychiatry and psychotherapy.

• 2017 to continue Lancet Commissioner for LMIC • 2014 to continue member of Teaching Course Committee, World Federation of Neurology (WFN). • 2014 – 2016 member of Scientific Committee of European Academy of Neurology (EAN). • 2013-2014 Rector of University of Medicine, Tirana • 2010 to continue Faculty in CONy Congresses • 2010-2013 Health National Contact Point, European Commission, CORDIS Fp7 programme • 2003 to continue: reviewer of European Journal of Neurology, Clinical Epidemiology, Neuropsychiatric Disease and Treatment, Journal of Epidemiology and Community Health, Journal of Pediatric Epilepsy, Patients and Reference, British Journal of Pharmaceutical Research, British Journal of Medicine and Medical Research, International Neuropsychiatric Disease Journal, BMJ Case Reports, etc. • February 2003 – 2011 – Trainer of European Academy of Epilepsy. • 2000 to continue: Member of editing board of OA Publishing London, WebMed Central Brain Editor, Confinia Cephalalgica, Parma, Emilia-Romagna, Italy; Contributer in Cochrane MS; Albanian Medical Journal, Albanian Journal of Medical and Health Sciences, University of Medicine, Tirana, • 1998-2007 - President of Albanian Society of Neurology (ASN). • 1997 to continue - Head of the University Service of Neurology (UHC Mother Teresa, Tirana). • 1981 to continue - Lecturer: Faculty of Medicine, Neurology Department. University of Tirana (University of Medicine since January 2013).

Neurology

Dr. Umeton is Research Associate at the Institute of Neuroscience, Newcastle University, investigating the neural computations underlying visual perception and stereopsis. Dr. Umeton received her PhD and postgraduate studies from University of Calabria, Italy, but has gain extensive research experience working for Newcastle University (UK), Calgary University (CA) and Universidad Complutence de Madrid (ES) .

Neural computations underlying visual perception and stereopsis

Dr. Fakhir Salman Al- Ani is a Professor of Department in Physiology and Pathology. He has completed graduation in MBBS from Baghdad University and post-graduation in Physiology and Pathology from Baghdad University and Ph.D. Physiology and Pathology from Baghdad University. He has more than 20 publications.

Physiology and Pathology

He was born in Tuzla on May 28, 1963. He finished elementary and high school as well as the medical faculty in Tuzla. He started working as an assistant trainee at the Institute of Pathophysiology, Faculty of Medicine Tuzla, University of Tuzla, in April 1989. Since October 1990, she works as a specialist at the Clinic for Orthopedics and Traumatology, JZU UKC Tuzla. By establishing the Department of Medical Informatics at the Faculty of Medicine, Tuzla was engaged as an assistant until 1996. As a companion of the wounded, he was sent to Iran in 1992. Since 1996 he has been employed at New Medical Center and National Medical Center, Abu Dhabi, UAE. Specialization in diagnostic radiology ends in 2003. Necessary knowledge from interventional vascular and neovascular radiology was acquired in 2003 at Rikshospitalet Oslo, University of Oslo, Norway. He received the title of Master of Medical Science after defending the topic under the title "Doppler ultrasonography and digital subtraction arteriography in the diagnosis of carotid artery disease", 2005. In November 2008 he was appointed Director of the Clinic for Radiology, Nuclear Medicine and Radiotherapy, JZU UKC Tuzla. In the same year, he received the title of Doctor of Medical Science after defending his work on the "Validity of computerized tomographic angiography in the diagnosis of cerebral vascular disease". He was appointed responsible teacher at the Department of Radiology and Nuclear Medicine at the Faculty of Medicine in Tuzla in May 2009. Since February 2011 he has been the Head of the Department of Medical Imaging in Radiology at the Pan-European University Apeiron in Banja Luka. He is currently serving as the President of the Tuzla Canton Medical Chamber. In October 2013 he was elected Chief of the Clinic for Radiology and Nuclear Medicine, JZU UKC Tuzla. Since November 2013, he has also been awarded the Diploma Manager in Healthcare at the Pan-European University Apeiron in Banja Luka. The teacher is responsible for the subject "General principles of health care" at the College of Medicine of the University of Tuzla from the school year 2009/10. He is a member of the commission for the specialist exam in "Diagnostic Radiology" since 2009. Member of the commission for evaluation and defense of master and doctoral papers in the field of radiology, informatics and physics.

Endovascular treatment of giant basilar artery aneurysm is a complex procedure that requires the work of an experienced team and a range of materials and techniques available. Treatment of a giant aneurysm of the basilar artery in the body which includes the initial parts of both arteriae cerebelaris posterior was a special kind of technical challenges and use techniques Waffle cone. Technically it was not possible to implement the classic waffle cone technique, and made modifications to the horizontal stenting in the right artery cerebelaris posterior, and above it are set Koil, and the aneurysm successfully closed with rear patent cerebellar artery. Technical correctly written procedure with good outcome for the patient left the question of objective verification of results. Using Voronoi diagrams and indirect visualization of the 3D models of aneurysms with the analysis of the dynamics of flow (flow dynamics), an objective verification of results. Results of verification coincide with the real results to the patient. The new method of analysis of endovascular treatment has proven to be an effective model verification results

Marina V. Zueva, Professor of Pathophysiology, PhD, Dr. Biol. Sci., graduated from the Lomonosov Moscow State University (Department of Physiology of Higher Nervous Activity), received her Ph.D. and Dr. Biol. Sci. degrees from Moscow Helmholtz Research Institute of Eye Diseases. Currently, she is the Head of the Division of Clinical Physiology of Vision at the Moscow Helmholtz Research Institute of Eye Diseases. Zueva is a member of International Society of Clinical Electrophysiology of Vision (ISCEV), European Association on Vision and Eye Research (EVER), European Society of Retina Specialists (EURETINA), the Society for Research on Biological Rhythms (SRBR). She has published over ten peer-reviewed papers in English (over 80 in Russian) and presented over 60 topics at international conferences.

Recently, we proposed and theoretically substantiated the hypothesis, which offers new approaches to treating neurodegenerative diseases of the retina and brain (Zueva, 2015). For the first time, we suggested that the impact of visual environmental cues of complex spatiotemporal structure on a person throughout his life is necessary for normal development and aging of the brain and visual system. The theory sets the link between the complexity of neural connections, nonlinear dynamics of physiological processes in the brain and the nonlinear characteristics of sensory cues. The loss in the complexity of neural networks in the retina and the brain develops in such socially relevant neurodegenerative diseases as glaucoma, diabetic retinopathy, Alzheimer’s disease, Parkinson’s disease, etc. The necessity of maintaining and strengthening of mental abilities in extreme situations and normal aging is a separate social and medical problem. The idea is to improve the scheme of neural circuits and brain’s function in normal and neurodegenerative diseases by nonlinear visual and other sensory stimuli with complex temporal structure through the reactivation of the brain plasticity. We can expect that the development of innovative non-drug technologies of impact on brain plasticity and definition of ways to manage this process will contribute to a more efficient recovery of neuronal contacts, cognitive functions, and overall functionality in patients with neurodegenerative disorders and amblyopia. The creation of devices for nonlinear sensory stimulation and the detection of mechanisms of its impact on the brain are crucial for therapeutic strategies, which can underlay of future breakthrough technologies.

Dr Khaled Goher has more than 15 years of experience in academia in Egypt, Oman, NZ and the UK. He joined the Biomedical Engineering Program, Aston University in July 2017. Dr Goher is a customer and market-oriented academic with special dedication to research for the benefit of the society. His principal research interests lie in the field of mobile robotics, personal care and assistive robotics while considering needs, preferences and expectations of elderly. Dr Goher is currently investigating the possibility of developing robotic walking devices and other assistive devices for manipulation, fall prevention and elderly mobility. He published a book, many high-quality articles and book chapters and has presented several research papers in various peer-reviewed international conferences. He holds a BSc and MSc in Mechanical Engineering, a PhD in Control Engineering from the University of Sheffield, and a PGCertHE from Auckland University of Technology. He supervised number of PhD students, two Master students, many senior design projects and tens of course-based projects. Dr Goher is internationally-engaged with various non-profits organizations. He is a member in the management team of CLAWAR association and a member of number of standardisation committees of the British Standards Institution (BSI).

we shall update research interest soon.

Tarit Kanti Ghosh MSc, MBBS, born in 1968 is a renowned Neurologist in Bangladesh. Since the very childhood he was extraordinary talented i.e. he always stood as topper in the class. In secondary school certificate & higher secondary certificate public exam he was one of seven among about 400,000 students all over the country. Being a son of a doctor his ambition was to become a benevolent physician. Thereby, he completed his graduation from the then British recognized medical college in Dhaka, Bangladesh in 1993. Then he did post-graduation(MSc) in internal medicine & Neurology from United Kingdom. He accomplished “Leading edge neurology for the practising clinicians, 2014” course in University college of London, UK. Due to thirst of knowledge he is still studying in the university of Melbourne, Australia in the Specialist Certificate Course in Clinical Research Neuroscience.

Abstract : This article reflects how surgery irrespective to age and/or organ becomes a prospective major health problem. In general about 50-60% patients undergone surgery suffer mild/moderate/severe psycho-biological illness in future for a long time due to feeling or fear that he/she (1:3) has lost part of body inside unhealed or prolonged healing process. so some neuro-psychiatric symptoms such as anxiety,tension,emotion and depression gradually burden their life style eventually leading to chronic stress (about 10%) along with some major health risks in 4-6 yrs after surgery.

Weimin Yang has completed his PhD from Sichuan University and visitor scholor studies from Melbourne University. He is the professor in Dept. of Neurology, First Affiliated Hospital of Zhengzhou University, master tutor, innovative talents of Henan Province Health Sciences and Technology. His research work mainly related to clinical features of Chinese stroke patients, stroke register, dementia, and systematic reviews of therapies from China. He has published more than 25 papers in reputed journals.

Background: Intracerebral hemorrhage (ICH) is a significant contributor to global health-related morbidity and mortality. Due to improved recognition and treatment of atrial fibrillation by antithrombotics, there is an increase in proportion of ICH caused by warfarin and novel oral anticoagulants. However, the relationship between anticoagulation intensity and hematoma expansion remains unclear. We aimed to investigate the effects of INR on hematoma expansion post ICH. Methods: We conducted a retrospective study of all patients hospitalized for ICH at a single institution from January 1, 2008 and August 1, 2014. Hematoma volumes on initial CT scans and repeat CT scans were analyzed by the AxBxC/2 method. Univariate analysis was used to compare baseline characteristics and median regression analysis was performed to estimate the effects of INR and hematoma volume changes. Results: We included 224 consecutive ICH patients. Median age (IQR) was 68.5 years (17.0), 60.3% were male, median presentation Glasgow Coma Scale (GCS) (IQR) was 14.0 (4.0), median volume (IQR) of the first CT was 11.7ml (25.6), median INR (IQR) was 1.1 (0.2). We showed that INR and time lapsed between first CT and second CT were independent risk factors to hematoma volume change, adjusting for baseline hematoma volume and time. For each 1.0 increase in INR was associated with hematoma volume increased by 2.4ml (p = 0.015). Conclusions: We showed that high INR was associated with hematoma growth post ICH. However, the effects of reversal anticoagulation in the attenuation of hematoma growth remain uncertain and require confirmation in future randomized controlled studies.

Andreas Melzer was born in 1960 and after studies in Mainz and Tuebingen he qualified in Dentistry in 1989 and as MD in 1993. He has 20 years experiences in the development of medical technology for laparo-endoscopic surgery, interventional radiology, interventional & intraoperative MRI and image guided robotics, surgical instrumentation, surgical robotics and Nitinol devices with more than 60 patents and over 200 publications, more than 500 oral and poster presentations. He has served as co editor of three medical journals, Co-founder and partner of six start-up companies in the medical technology business and consultant for major vendors in medicine. He serves as organizer or chairman of various medical conferences and board member of six medical and technical societies. He currently is Professor of Medical Technology and Director of the Institute for Medical Science and Technology IMSaT, a joint venture of the Universities Dundee and St Andrews, Scotland.

Applied Biomedical Sciences, Dentistry

Sarah Crawford received a Master’s Degree in Biochemistry from Princeton University in 1982 and a PhD Degree from the Department of Biochemistry and Biophysics, Columbia University College of Physicians and Surgeons in 1987. She has been affiliated with Southern Connecticut State University for over 20 years and is currently the Full Professor in the Department of Biology where she teaches Genetics and Medical Genetics and directs a research laboratory in cancer biology. In 2013, she was awarded a patent by the US Patent Office for a novel cancer treatment for the brain cancer, glioblastoma.

Her research interest includes genetics and cancer biology.

Dr. Pant received his M.A. and Ph.D. degrees in Physics from Agra University, Agra, India. His postdoctoral studies were conducted on the mechanisms of electron and ion transport in model membrane systems at the Department of Biophysics at Michigan State University. He joined the Laboratory of Neurobiology in the NIMH as a senior staff fellow in 1974 with Dr. Ichiji Tasaki where he studied the function of the axonal cytoskeleton in the squid giant axon. In 1979 he moved to the NIAAA extending his studies on the neuronal cytoskeleton and the effects of alcohol on its regulation. Dr. Pant moved to the NINDS, Laboratory of Neurochemistry in 1987 where he is presently chief of the section on Cytoskeleton Regulation. His laboratory is studying the mechanisms of topographic regulation of neuronal cytoskeleton proteins by post-translational modification, including the role of kinase cascades in normal brain and during neurodegeneration.

The major focus of this laboratory has been to study the mechanisms of topographic regulation of neuronal cytoskeletal proteins regulation by phosphorylation and neurodegeneration. In a normal physiological state, cytoskeletal proteins are phosphorylated extensively in the axonal compartment of a mature neuron. Although all the substrates, kinases, phosphatases and their regulators are synthesized in neuronal cell bodies, little or no cytoskeletal protein phosphorylation has been detected in the cell body compartment. Under a variety of neuropathological conditions, however, such as ALS, Alzheimers Disease, or Picks disease, hyperphosphorylation of these molecules has been found in abnormal aggregates within cell bodies, usually correlated with massive neuronal cell death. The mechanisms underlying these profound compartmental shifts in neuronal phosphorylation are not well understood.The normal physiological processes within neurons are controlled by signal transduction mechanisms that regulate the balance between protein kinase and protein phosphatase activities. We have shown that the most abundant and extensively phosphorylated motifs in the c-terminal domains (lys-ser-pro-, or KSP) are primarily phosphorylated by proline directed kinases, cdk5 and MAP kinases. Moreover, we have demonstrated that this phosphorylation is due to activation of the signal transduction cascade. Recently, we have focussed on the other part of this regulation, the protein phosphatases. The other project is to study the expression, regulation and role of neuronal Cdk5 in nerve cell function.Cdk5 is a unique multifunctional kinase. Unlike other cyclin-dependent kinases, it is expressed predominantly in post-mitotic neurons, its activity modulated by association with nervous system-specific propeins. Since its identification and characterization in our laboratory, we have been intensively studying its mechanisms of regulation and its role in nerve cell function.

Awojoyogbe O. Bamidele has B.Sc (1986), M.Sc (1991) and obtained Ph.D (1997) from Federal University of Technology, Minna, Nigeria in collaboration with the Institute of Biomedical Engineering and Medical Informatics, University and ETH, Zurich, Switzerland. He won the 2003 Young African Mathematician Medal Award by African Mathematical Union at AMU-ICMS. He has published more than 50 papers in reputed journals and has served at various academic and administrative levels within the university.

computational magnetic resonance imaging and theranostic of brain tumors

Benjamin Chitambira completed his BSc Physiotherapy Honours degree from the University of Zimbabwe in 1995. He also completed a Postgraduate Certificate in Healthcare Leadership from the Open University in the UK in 2014. With over 19 years’ experience as a neuro-physiotherapist, he has been carrying out research on optokinetic chart stimulation as a clinical specialist physiotherapist in the Richard Stevens Stroke Unit for over 8 tears.With over 9 papers published in peer reviewed journals, he has been a peer reviewer for reputable journals and now serves as an editorial board member of peer reviewed journals.

Background: This presentation aims to describe optokinetic chart stimulation and its evolution as a recovery focused neurorehabilitation intervention. Stroke, traumatic brain injuries and critical care polyneuropathy and or myopathy can cause severe disability. Methods: The optokinetic chart is made of laminated A4 paper. It consists of repeated bundles of the colours of the rainbow. The chart is placed 20 centimetres in front of a patient’s face. It is moved from side to side atapproximately one cycle per second for 3 minutes. This is followed bymoving the chart up and down for 3 minutes and then forwards and backwards for another 3 minutes. Results: The first task was to identify which strokes benefited most from the intervention. A case seriespublished in 2011 identified that strokes not involving simultaneous infarcts or haemorrhages of parietal and temporal lobes recovered movements. A case control series published in 2014 demonstrated statistically significant upper limb recovery (P<0.05). The author has been pilot-testing to see if these differences are reproducible under randomized controlled trial conditions. First set of comparable results point to the potential of a future full trial achieving an all and none principle of the ideal scientific experiment. Preliminary efficacy has also been demonstrated in difficult to rehabilitate traumatic brain injuries and critical care polyneuropathies and or myopathies. Conclusion: Optokinetic chart stimulation shows promise as a novel recovery focused neurorehabilitation intervention. Further research with fully powered studies is required to provide evidence for its inclusion in future guidelines.

Dr. Badgaiyan received training in psychiatry and cognitive neuroscience at Harvard University, University of Pittsburgh and University of Oregon. His research is focused on the study of neural and neurochemical mechanisms that control the human brain functions. He developed the single scan dynamic molecular imaging technique to detect, map, and measure neurotransmitters released acutely in the human brain during task performance. Using this technique he studies dopaminergic control of human cognition and behavior. He is also interested in learning the nature of dysregulated dopamine neurotransmission in different psychiatric and neuropsychiatric conditions. He is particularly interested in the brain mechanisms that control conscious experiences at cortical and subcortical levels. His research is funded by NIMH, NINDS, VA, and various research foundations. Currently he is a Professor of Psychiatry and Neuromodulation scholar at University of Minnesota at Minneapolis. He is also the Director of Laboratory of Advanced Radiochemistry and the Laboratory of Molecular and Functional Imaging.

His research focuses on the study of brain mechanisms that are responsible for abnormal behavioral, cognitive and emotional processing. He uses a novel dynamic molecular imaging technique (that he recently developed), to detect changes in the brain neurochemistry. He also uses cutting edge functional MRI techniques to study psychiatric and neuropsychiatric conditions. He is primarily interested in understanding the behavioral and cognitive effects of dysregulated dopamine neurotransmission. His research is funded by the grants from National Institutes of Health and Veteran’s Administration.

Paria Arfa-Fatollahkhani is a medical intern of Iran University of Medical Sciences. Her enthusiasm to progress was intensified in the fields of neurology and neuroscience.

Short-term and long-term effects of treadmill training on the balance, functional capacity and quality of life in patients with Parkinson disease- A randomized clinical trial

Prof. Wang Rongfu has completed his Ph.D in Pharmacology from Toulouse Paul Sabatier University (Toulouse III), Toulouse, France in 1995. He received many awards and honors. Currently he is working as a Professor& Director, Department of Nuclear Medicine, Peking University Health Science Center & Peking University First Hospital.

....

Abbas Alnaji had his Board degree of Neurosurgery from University of Baghdad and the consultant from Iraqi ministry of health 2015. Interested in the biological bases of medic-surgical pathologies in his field. Took share as a speaker in more than 30 world events and conferences.

Illnesses treated symptomatically had got causes! categorizing them as of not known etiology is for a while! One of the main pillars to disclose these causes is the clinical trial treatment CTT; it may exceed the other means, where it works when they are depleted. CTT has its civilization to be applied. It is the link among philosophy, clinical practice and applied sciences. Starts by looking for the truth, maintained by the perseverance and end by the smart perception. A wise man once said ‘’ the admiration prevents from increment’’ this is the philosophy. It refers to the satisfaction in what if we are on, will stop further discovery of diseases causation. The route is paved with difficulties, so needs insistence. Results of CTT are the meticulous harvest of each step of the route. For that, in my career, by applying the above three basis, I can say, good gain was obtained through; chronic low back pain, carpal tunnel syndrome, MRI signs had been satisfactorily knew their reality. and several others will be discussed in more reality in near future, the ignition for that was the clinical trials.

Dr. DeFeo is noted as one of the leading experts of the DSM-5 in the State of California. She has conducted over 50 state, national, and international trainings on the topic. Dr. DeFeo was the highlighted presenter at the 18th Annual Inter-national Violence, Abuse, and Trauma Conference (IVAT) in San Diego in September, 2013, the 18th Annual IVAT Conference in Honolulu, Hawaii in March, 2014, and the Illinois American Association for Marriage and Family Therapy Annual Conference in Naperville, Illinois to conduct a full 7 hour workshop to educate Clinical Psychologists, Social Workers, Marriage and Family Therapists, Psychiatrists, and Medical Doctors/Professionals on the DSM-5 and ICD-10 diagnostic systems. Dr. DeFeo’s DSM-5 and ICD-10 training is also an approved accredited workshop with the Association for Advanced Training in the Behavioral Sciences (AATBS) to train social workers, psychologists, psychiatrists, medical physicians, and marriage and family therapists in the United States. Additionally, Dr. DeFeo is working with the Mexican Board of Professionals to institute the DSM-5 into the Mexican Higher Education Institutions, and has presented this topic at the First Annual Psychological Society Conference in Buenos Aires, Argentina in October, 2014 and various locations in Mexico (Tijuana, Ensenada, and Mexicali). Dr. DeFeo presently is a California licensed psychologist, distinguished professor of psychology, and Interim Associate Chair for the Department of Marriage and Family Therapy at the Chicago School of Professional Psychology in Irvine, California where she has been working since 2010. Dr. DeFeo also is a senior reviewer and editor for the Journal of Psychiatry, OMICS, and the Journal of Hispanic Higher Education.

Dr. George Perry is currently the dean of the College of Sciences and professor of biology at the University of Texas at San Antonio. After graduation in Zoology from University of California, Santa Barbara, he headed to Scripps Institution of Oceanography and also studied at Hopkins Marine Station of Stanford University and the Marine Biological Laboratory of Woods Hole and obtained his PhD in Marine Biology in 1979. Dr. Perry joined the faculty of Case Western Reserve University in 1995, where he currently holds an adjunct appointment. He is a Fellow of the American Association for the Advancement of Sciences, Microscopy Society of America, Royal Society of Medicine, Royal Society of Chemistry, Society of Biology and the Linnean Society and past-president of the American Association of Neuropathologists. He has been elected member of the Spanish Royal Academy of Sciences, Mexican Academy of Sciences and Academy of Sciences Lisbon; Iberoamerican Molecular Biology Organization, Dana Alliance for Brain Initiatives and won the Distinguished Professional Mentor Award from the Society for the Advancement of Chicanos and Native Americans in Science, Senior Investigator Award from the International College of Geriatric psychoneuropharmacology, Senior Fulbright Fellow and the National Honor Plaque of Panama for exceptional contributions to Neuroscience. Dr. Perry is on Board of the National Organization of Portuguese Americans and serves as Director of Education and Research.

Guy H Fontaine has made 15 original contributions at the inception of pacemakers since early 60s. He has serendipitously identified Arrhythmogenic Right Ventricular Dysplasia in the late 70s. He has published more than 900 scientific papers including 201 book chapters. He was the reviewer of 17 journals in Clinical and Basic Science. He served during 5 years as a Member of the Editorial Board of Circulation. He has been invited to give 11 master lectures of 90 minutes each during three weeks in the top universities of China (2014).

Dr. Wang is Director of Neuroapoptosis Drug Discovery Laboratory, Department of Neurosurgery, Brigham and Women’s Hospital/Harvard Medical School. Dr. Wang received her PhD from Hebrew University of Jerusalem. She did her postdoctoral training at University of Michigan and Harvard Medical School. Dr. Wang has published about 70 peer-reviewed articles and has served as the Guest Editor, Handling Editor, and Editorial Board Member for a number of peer-reviewed journals, as well as the scientist reviewer for institutes or foundations including NIH, DOD, BSF, and others, and invited reviewer for 34 peer-reviewed journals.

Currently I am working as Research Scientist in the Department of Neurology at University of Iowa, Iowa, USA. I did my B.Sc. (Chemistry) in 2003, M.Sc. (Organic Chemistry) in 2005 from Aligarh Muslim University and Ph.D. (Toxicology) in 2009 from the department of Toxicology, Hamdard University, Delhi, India. After completion of my Ph.D. program, I have joined the Department of Internal medicine as postdoctoral Research Associate. Here I focused my research on understanding the role of plasma glycoprotein von Willebrand factor (VWF) and VWF-cleaving protease ADAMTS13 in animal model of stroke. After that I joined the department of Neurology as an Associate Scientist. Here my research investigates the molecular mechanisms that regulate inflammation in the central nervous system that are critical to our understanding of a broad spectrum of neurodegenerative diseases, including Parkinson’s disease, stroke, Alzheimer’s disease, multiple sclerosis and traumatic brain injury. I am the member of several international societies and enlisted in the Editorial board of the journal.I have published almost 40 peer reviewed original research publications and almost 50 abstracts in National and International Neuroscience-related meeting and conferences.

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. Professor Tang completed his medical training at the Chinese University of Hong Kong. He joined the Chinese University of Hong Kong as an academic staff since 1999. His main research area is Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

Kurt A Jellinger, born 1931 in Vienna, is Professor of Neurology and Neuropathology at the Medical University of Vienna (Vienna, Austria), was director of the Department of Neurology, Lainz Hospital in Vienna and since 2002, director of the Institute of Clinical Neurobiology (Vienna, Austria). He has been the recipient of numerous international grants and awards, is a member of numerous national and international scientific societies, editor of many international journals of neurology, neuroscience and neuropathology. His publication records exceeds 1,000 in perr-reviewed journals, 170 contributions in scientific book, inclduding several as editor, as well as 1.300 lectures at international meetings. For the last 50 years, his research included many fields of clinical neuropathology, neurochemistry and descriptive neurobiology.

Wang is Director of Neuroapoptosis Drug Discovery Laboratory, Department of Neurosurgery, Brigham and Women’s Hospital/Harvard Medical School. Dr. Wang received her PhD from Hebrew University of Jerusalem. She did her postdoctoral training at University of Michigan and Harvard Medical School. Dr. Wang has published about 70 peer-reviewed articles and has served as the Guest Editor, Handling Editor, and Editorial Board Member for a number of peer-reviewed journals, as well as the scientist reviewer for institutes or foundations including NIH, DOD, BSF, and others, and invited reviewer for 30 peer-reviewed journals.

Identification of candidate therapeutics for Amyotrophic Lateral Sclerosis, Huntington’s disease, and ischemic stroke; Fundamental mechanisms of neurological diseases.

Marie Trad is an Executive Medical Director, acting currently as the Medical and Scientific Drug Development lead in Neurosciences within the CNS Therapeutic Delivery Unit at Quintiles. Trad is a board certified Neurologist and qualified Neuroradiologist from the Pierre and Marie Curie University of Paris, France. She has over 25 years of CNS experience of which 11 years as a clinical Neurologist/Neuroradiologist and 14 years of pharmaceutical industry, focusing on clinical trial management, providing medical, clinical and global strategic support related to Neurology and Psychiatry trials.

Drug Development in Neurosciences,Neuroradiology,clinical Neurology

Kaja is an experienced neurobiologist with a long-standing research track record in academia and the biotech and pharmaceutical industry. Kaja currently serves as Associate Director of Preclinical Research at the Vision Research Center at the University of Missouri - Kansas City, School of Medicine. He is the Director of Microscopy of the imaging core facility at the Vision Research Center and also holds an appointment to Assistant Professor of Ophthalmology. His NIH-funded research program focuses on human neurological and neurodegenerative diseases, visual disorders and inflammation. Kaja obtained his B.Sc. (Hons.) degree in Molecular Biology and Biochemistry from Durham University, UK and holds a Ph.D. degree in Medicine/Neuroscience from Leiden University, The Netherlands. Prior to joining the faculty at the University of Missouri - Kansas City, he has performed postdoctoral work at The University of British Columbia (Vancouver, B.C., Canada) and the University of North Texas Health Science Center (Fort Worth, TX). In addition to his academic work, Dr. Kaja has worked and consulted for a number of pharmaceutical companies, incl. Novo Nordisk A/S, Bayer AG, Neuromed Pharmaceuticals Inc., and NeuroSearch A/S. He is CEO and co-founder of K&P Scientific LLC, a scientific consulting company headquartered in Kansas City, MO.

Pathophysiological mechanisms underlying neurodegenerative, neurological and visual disorders.

Amina S. woods is an investigator at integrative neuroscience branch, structural biology unit, NIDA. Woods obtained her B.Sc degree in chemistry at Loyola College. After graduation, she joined Department of Pathology and went to University of Maryland Medical School and obtained her M.S. She received a Ph. D in Pharmacology and Molecular Sciences from Johns Hopkins School of Medicine. She has undergone Post-doctoral training in Oncology Immunology, Johns Hopkins School of Medicine (Advisor Elizabeth Jaffee). Dr. Woods received “Woman Scientist Achievement Award” from NIDA in 2011.

Functional proteomics, mapping and imaging of the brain’s and other organs, lipidome and proteome of leucocytes, protein modeling and bioinformatics

Maria Victoria Tejada -Simon is an Associate Professor of Pharmacology, Biology and Psychology, and member of the Biology of Behaviour Institute at the University of Houston in Houston, Texas. Current research in her laboratory examines the role of small GTP-binding proteins in cognition, with emphasis in mental retardation, schizophrenia, neurodegenerative as well as autistic disorders.

Pharmacology,Psychology,schizophrenia,neurodegenerative disorders

Jerzy Leszek is full professor of psychiatry at the Medical University in Wroclaw , Poland ,vice –director of the Psychiatry Department and head of Alzheimer’s Disease Lab. He is author and co-author more than 210 papers (especially from old age psychiatry), some chapters to the books published in reputed Polish and international journals and serving as an editorial board member of several journals .He is Scientific Editor and co-author of first Polish academic handbook on Alzheimer’s disease and seven another academic handbooks from psychogeriatry , member a lot of scientific associations eg founder and president of Lower Silesian Association of Alzheimer’s Families, first of its kind in Poland and Former Member of Board of Directions of International Psychogeriatric Association and President of Polish Psychogeriatric Association.

Psychiatry,Alzheimer’s Disease

Fakhir Al-Ani has completed his M.Sc. study and PhD study from Baghdad University ,College of Medicine. School of Medicine. He spend about 30 yars as a teaching staff in medical college. He is now working in Mutah University, Medicl College as the head of Physiology & Pathology Dept. He has supervised more than 13 Ph.D thesis, and more than 23 M.Sc. thesis. He has published more than 35 papers in reputed journals.

Neurophysiology/ Electrophysiology EEG, EMG, Evoked potential

Wang is Director of Neuroapoptosis Drug Discovery Laboratory, Department of Neurosurgery, Brigham and Women’s Hospital/Harvard Medical School. Dr. Wang received her PhD from Hebrew University of Jerusalem. She did her postdoctoral training at University of Michigan and Harvard Medical School. Dr. Wang has published about 70 peer-reviewed articles and has served as the Guest Editor, Handling Editor, and Editorial Board Member for a number of peer-reviewed journals, as well as the scientist reviewer for institutes or foundations including NIH, DOD, BSF, and others, and invited reviewer for 30 peer-reviewed journals.

Identification of candidate therapeutics for Amyotrophic Lateral Sclerosis, Huntington’s disease, and ischemic stroke; Fundamental mechanisms of neurological diseases.

Guangping Gao, Ph.D., is the Director of the Gene Therapy Center and Penelope Booth Rockwell Professor in Biomedical Research, UMass Medical School. He is also a scientific founder of Voyager Therapeutics. He received his Bachelor Degree in Medicine from Sichuan University, China, and Ph.D. in molecular genetics at Florida International University with his work on discovering the human aspartoacylase gene and the genetic mutations responsible for Canavan’s disease. He joined the Institute for Human Gene Therapy (IHGT) at University of Pennsylvania in 1994 and served as the Director of Vector Program of IHGT for vector discovery, process development, vector manufacturing and QC testing. One of his most important contributions to the field of gene therapy is his discovery of a novel family of highly efficient and safe AAV vectors. His primary research interests include molecular mechanisms of AAV evolution, microRNA functional genomics in adult mammals, biology and clinical applications of miRNA therapeutics, and gene therapy of CNS disorders. He has published more than 150 papers in peer-reviewed journals and has 26 patented inventions. He served on several international committees for gene therapy. He is the senior editor of the Book Series on Gene and Cell Therapy publishing by ASGCT and Springer Publisher and serves on Advisory Board of Advances in Experimental Medicine and Biology

Molecular mechanisms of AAV evolution, microRNA functional genomics in adult mammals, biology and clinical applications of miRNA therapeutics, and Gene therapy of CNS disorders

Guang-Xian Zhang earned his Ph.D from Karolinska Institute, Stockholm, Sweden, in 1996 and began postdoctoral studies at the University of Pennsylvania School of Medicine in 2000. He is currently professor at the Department of Neurology, Thomas Jefferson University, and co-director of the Neuroimmunology Laboratories at this institution. He has published more than 80 peer-reviewed papers. He has also served as a reviewer for first-class journals, and as a reviewer on study section rosters in several funding agencies. His studies mainly focus on using neural stem cells as a novel approach for treatment of human multiple sclerosis, via mechanisms of immunomodulation, neural cell repopulation and neuroregeneration.

Neural stem cells/gene therapy in multiple sclerosis (MS), Neurological autoimmune diseases

Education / Training 1986 - Ecole Normale Superieure (Life Science). 1991 - Ph.D. Neuroscience (Bordeaux University). 1998 - Habilitation (Paris XI University, School of Medicine). Present Position Head of the Laboratory \\\\\\\"Perception and Memory\\\\\\\" at the Pasteur Institute Director of the Unit \\\\\\\"Genes, Synapses and Cognition\\\\\\\" at the French Center for Scientific Research (CNRS) Director of a PhD program \\\\\\\"Neuroscience at the Pasteur Institute\\\\\\\"

Modern neurosciences

Rafi is a Professor of Neurology at Thomas Jefferson University, Philadelphia. He has received his PhD in Animal Biology from the University of Montpellier, France. He has taught Cell and Molecular Biology for 16 years at the School of Science, Tabriz University, Iran where he sustained the Chairmanship of the Biology Department for several years before moving to the USA. While working in several lysosomal storage diseases, his main research is currently focused on gene therapy of globoid cell leukodystrophy (Krabbe disease) in animal models of this disorder

Lysosomal disorders, Gene & cell therapy of leukodystrophies

Dr. Trevor Archer is a Professor of Psychology in University of Gothenburg, Sweden. He did his PhD, in Psychology from the Uppsala University, Uppsala, Sweden in 1979. He served as a Professor of Psychology in Umeå University, Göteborg University, Karlstad University, Örebro University, Madrid Complutense, Kalmar University, Sweden, Visiting Professor, University of Hawaii at Manoa, USA; Madrid University, Spain, La Sapienza University, Rome, Italy. Dr. Archer is an author of more than 484 publications & many books. He is an Editorial Board member & Reviewer for many Journals.

Psychology,Neurotoxicity Research

Walter E. Muller is a Professor of Pharmacology.He is now serving as a Chairman, Department of Pharmacology,Biocentre,University of Frankfurt.He is graduated from School of Pharmacy,University of Frankfurt with a Doctoral degree in department of pharmacology from University of Mainz school of medicine.He is a Honorary member of Austrian Society for Neuro Psychopharmacology and Biological Psychiatry and was awarded in Psychopharmacology,German Association for Neuropsychopharmacology(AGNP)in 2009,Award in German Secretary for Science and Education in 1978.He has a Fellowship in American College of Neuropsycho-pharmacology. He had published 21 Books,129 Book chapters.Reviewed 189 Articles,has 320 Original publications with Hirsch-index: 63 & i10-index: 278.

Neurodegeneration and neuroprotective agents, Oxidative stress and antioxidants, Anti-depressant and anxiolytic mechanisms

Dikranian is an Associate Professor of the Department of Anatomy & Neurobiology in Washington University , USA. He received his MD from Medical University, Varna, Bulgaria in 1978 & PhD from Medical Academy, Sofia, Bulgaria in 1992. Dikranian have extensively studied the morphology of the vascular and nervous systems including the enteric nervous system. In the last 15 years the focus of his scientific interest has been the pathomorphology of the central and peripheral nervous systems. In ongoing projects with the Department of Neurology I am studying the development of neuronal and axonal changes after brain trauma and in transgenic mice expressing mutations common in Alzheimer’s disease. Mapping the human macro-connectome represents a grand challenge for the coming century and the field of connectomics received a major boost with the launching of the Human Connectome Project (HCP) in 2010. This is a large-scale NIH-sponsored effort to map the human connectome in healthy adults. Diffusion imaging and resting-state fMRI represent the two main modalities for examining the macro-connectome in vivo. My contribution to the project relates to combining and navigating MRI data with data from histological studies on primates by tracking trajectories of axonal pathways between the white matter and gray matter. Dikranian been a reviewer for many reputed Journal & author for many publications & books.

Pathomorphology of the central and peripheral nervous systems.

Meguid is an experienced clinical geneticist . Currently served as a professor of human genetics at the National Research Center (NRC) in Egypt. Holds her Ph.D. in Human Genetics, Senior Geneticist at the Genetics Institute, Pasadena, California; a fellow of Uppsala University, Sweden; fellow at Yale University USA. She was one of five selected scientists to win the outstanding L’Oreal UNESCO Award for women in Science for Africa & Middle East (2002). She is the head and running a Clinic and Laboratory for children with neurogenetic disorders focusing on genetics of autism. Currently she is a member in the Regional Bio-Ethics Society and committed to Gender Research in Africa into Information Communication Technologies for Empowerment.

Neurodevelopmental research particularly autism, syndrome identification

Carlos Jorge Rubinstein is a Professor of Medicine at Universidad de Buenos Aires (UBA)and Head of Teaching and Research at Hospital Dr. F. Abete. Dr. Rubinstein was born in Buenos Aires, Argentina, studied at the Faculty of Medicine of the University of Buenos Aires. He received his medical degree in 1990. He completed his residency at the Hospital Dr. Ramon Carrillo. It Intern Medicine specialist, Psychiatry and Geriatrics. Teaching UBA School of Medicine, director of graduate studies in geriatrics at this university. Staff in Trauma and Emergency Hospital Dr Federico Abete (teaching Hospital), Head of Teaching and Research at same hospital. He is a member counselor of the Colegio Medico of the Province of Buenos Aires, a member of the Society of Internal Medicine of Buenos Aires and mamber of Argentina Medical AssociationBiography

Psychiatry, Medical Psychology, and GeriatricsResearch Interest

Yusaku Nakabeppu is a Professor at the Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Japan. He is now serving as the Director of Research Center for Nucleotide Pool, Kyushu University. Dr. Nakabeppu graduated from Graduate School of Sciences, Kyushu University, with a Doctor of Science degree in 1984. He has performed postdoctoral work at Johns Hopkins University School of Medicine (in Professor Daniel Nathans’s Lab; 1987 to 1990). In 1997, he was appointed as a Professor at the Medical Institute of Bioregulation, Kyushu University, and elected as a Distinguished Professor at Kyushu University in 2010.

Neurofunctional genomics

Education 1988 BSc in Biological Sciences, University of Milan 1992 PhD Degree in Molecular and Cellular Biology, University of Milan Professional experience 1992-1997 Postdoctoral fellow, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany 1998 – to present Group Leader, San Raffaele Scientific Institute, Milan, Italy 1998 – to present Professor of Psychobiology, University San Raffaele, Milan, Italy 2003 – to present Council Member of the Molecular and Cellular Cognition Society 2006 – to present President of the European Molecular and Cellular Cognition Society 2007 – to present Editorial Board Member of Frontiers in Behavioral Neuroscience

Neurosciences,Dysfunctions associated to Parkinson’s disease